Related Experiment Video
Updated: Aug 8, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Variations in the peroxisome proliferator-activated receptor-gamma gene and melanoma risk
Rotraut Mössner1, Peter Meyer, Florian Jankowski
1Department of Dermatology, Georg-August-University, Von-Siebold-Strasse 3, D-37075 Göttingen, Germany.
Abstract:
There is strong evidence to suggest that the peroxisome proliferator-activated receptor (PPAR)-gamma, a member of the nuclear receptor family of transcriptional regulators, mediates tumor suppressive activities in a variety of human cancers. Recently, PPARgamma agonists were found to inhibit growth of melanoma cell lines. Here, we tested the possibility that variations in the gene encoding PPARgamma (PPARG) influence melanoma risk. Two variations of PPARG (P12A[rs1801282] and C161T [rs3856806]) were investigated in two independent case-control studies with a total of 832 melanoma patients and 790 control individuals. In the first study, homozygous carriers of the rare *T allele of the C161T polymorphism in exon 6 of PPARG were significantly more common among patients with melanoma than among healthy subjects (6.0 vs. 2.0%; P=0.0096) and this association was independent of clinical risk factors such as skin type and nevus count (odds ratio 5.18; 95% confidence interval 1.68-15.96; P=0.0041). This finding, however, could not be replicated in the second case-control study. We therefore conclude that the investigated PPARG polymorphisms are not likely to constitute a significant risk factor for the development of melanoma among German Caucasians.
Insights
Genetic variations in the PPARG gene were studied for their link to melanoma risk. While one study suggested a link, a second study did not replicate the findings, indicating no significant association.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Peroxisome proliferator-activated receptor (PPAR)-gamma is a nuclear receptor with tumor-suppressive roles in various cancers.
- PPARgamma agonists have demonstrated inhibitory effects on melanoma cell line growth.
- Investigating genetic variations in PPARG could elucidate their influence on melanoma susceptibility.
Purpose of the Study:
- To investigate the association between specific genetic variations in the PPARG gene and the risk of developing melanoma.
- To evaluate two common PPARG polymorphisms (P12A and C161T) in relation to melanoma risk.
Main Methods:
- Two independent case-control studies were conducted, involving a total of 832 melanoma patients and 790 control individuals.
- Genotyping was performed for two PPARG variations: P12A (rs1801282) and C161T (rs3856806).
- Statistical analyses, including odds ratios and confidence intervals, were used to assess the association between genotypes and melanoma risk, adjusting for clinical factors.
Main Results:
- The first study indicated a significantly higher frequency of homozygous carriers of the rare *T allele of the C161T polymorphism among melanoma patients compared to controls (6.0% vs. 2.0%, P=0.0096).
- This association in the first study was independent of clinical risk factors (OR 5.18, 95% CI 1.68-15.96, P=0.0041).
- The observed association between the C161T polymorphism and melanoma risk could not be replicated in the second independent case-control study.
Conclusions:
- The investigated PPARG polymorphisms (P12A and C161T) are unlikely to represent a significant risk factor for melanoma development in the studied German Caucasian population.
- Further research may be needed to fully understand the complex genetic underpinnings of melanoma susceptibility.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a superfamily...
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Cancer Prevention
Some...
